Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekAJMC ↗
First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD…
The WeekBioPharma Dive ↗
A possible alternative to "anti-CGRP" medications, the drug didn't meet some analysts' expectations in mid-sta…
The WeekPharmaVoice ↗
While the large pharma's new drug Cobenfy has stumbled in schizophrenia, it could find new life in Alzheimer's…
The WeekPharmaVoice ↗
From hepatitis B to melanoma, recent study results show innovative approaches are gaining ground.…
The WeekFiercePharma ↗
With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its…
The WeekFierceBiotech ↗
On Thursday, the public had the first chance to air their grievances about the FDA's controversial Commissione…
The WeekBriefing
The Trump administration plans to strip job protections from around 8,000 NIH officials overseeing research gr…
The WeekDrug Channels ↗
Today's guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS…
The WeekDrug Channels ↗
Today's guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS…
The WeekDrug Channels ↗
Today's guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS…
The WeekSTAT News ↗
OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effect…
The WeekAJMC ↗
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata…
The WeekBioPharma Dive ↗
The RNA-focused drugmaker says Inceptive's tools will help prioritize the best development options as well as …
The WeekFiercePharma ↗
In response to a planned healthcare reform initiative in Germany that would reduce the prices of branded drugs…
The WeekFierceBiotech ↗
Alnylam has partnered with the person who helped put the "T" in ChatGPT, paying $30 million to work with Jakob…
The WeekBriefing
Even before approval, Revolution Medicines’ pancreatic cancer asset is prompting discussion of how and when it…
The WeekSTAT News ↗
Ambient scribes were the first large-scale application of AI in health care. Now developers are pitching them …
The WeekBioPharma Dive ↗
Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients…
The WeekAJMC ↗
How Often Do Health Insurers Deny Doctor-Recommended Care?…
The WeekPharmaVoice ↗
As NASA prepares to bring its hallmark space lab back to Earth, a host of private companies are emerging to f…
The WeekFiercePharma ↗
For Meghan O'Hora, pharma marketing isn't about patients. It's about people and making real connections that h…
The WeekFierceBiotech ↗
Anti-aging startup NewLimit is back with a fresh fundraise of $435 million after landing on its first clinic-r…
The WeekBriefing
The agency’s Complete Response Letter delays CTx‑1301, the biotech’s first commercial hopeful, over CMC issues…
The WeekSTAT News ↗
A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.